American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...
15h
Medpage Today on MSNSemaglutide Tied to Small Risk of Potentially Blinding Eye ConditionThe use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...
Circana provides Ahold Delhaize USA companies with analytical support to inform decision-making, boost supply chain ...
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
The quick answer is, it's complicated. Number one, quality. Number three, delay of the product. because it's no longer ...
Alembic is introducing diltiazem hydrochloride extended-release capsules 120 mg, 180 mg and 240 mg, which are the generic of ...
An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol.
Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...
A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...
For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results